# Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and Hospitalizations

> **NCT01460862** · — · WITHDRAWN · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01460862
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-05
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** company decision
- **Last updated:** 2021-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01460862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01460862, "Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and Hospitalizations". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01460862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*